argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: FBRX) | Delayed: 76.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $76.99 | 52 Week High | $ | |||
| Open | $76.99 | 52 Week Low | $ | |||
| Day High | $76.99 | P/E | N/A | |||
| Day Low | $76.99 | EPS | $ | |||
| Volume | 432,186 | |||||
